Spironolactone
Product Images NDC 21695-960

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 21695-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

This Is An Image Of The Structural Formula For Spironolactone. (E5bf608e C6dd 44e8 96aa Ba4660f64de0 01)

This Is An Image Of The Structural Formula For Spironolactone. (E5bf608e C6dd 44e8 96aa Ba4660f64de0 01)
Chemical structure of spironolactone showing its molecular framework with labeled atoms and functional groups. The molecular formula is C24H32O4S and the molecular weight is 416.57.*
FDA Label Image

This Is Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 02)

This Is Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 02)
A Kaplan-Meier survival curve comparing the probability of an event over time in months between Spironolactone and placebo groups. The graph shows two lines, one for Spironolactone (n=822) and one for placebo (n=841), with a log-rank p-value of less than 0.001, indicating a statistically significant difference.*
FDA Label Image

This Is An Image Of Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 03)

This Is An Image Of Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (E5bf608e C6dd 44e8 96aa Ba4660f64de0 03)
A forest plot chart displaying hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The chart compares outcomes between spironolactone and placebo, showing subgroup sizes (N) on the right.*
FDA Label Image

Spironolactone 50mg (E5bf608e C6dd 44e8 96aa Ba4660f64de0 04)

Spironolactone 50mg (E5bf608e C6dd 44e8 96aa Ba4660f64de0 04)
Label for Spironolactone 50 mg tablets, 60 count, produced for Qualitest Pharmaceuticals by Physician Partner. The label includes NDC 21695-960-60 and notes the tablets are white, oval, film-coated, and debossed with "58" and "81" on one side and "V" on the reverse. Storage instructions advise controlled room temperature (15°-30°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.